Načítá se...
Facilitating treatment of HCV in primary care in regional Australia: closing the access gap
BACKGROUND: Australia has unrestricted access to direct-acting antivirals (DAA) for hepatitis C virus (HCV) treatment. In order to increase access to treatment, primary care providers are able to prescribe DAA after fibrosis assessment and specialist consultation. Transient elastography (TE) is reco...
Uloženo v:
| Vydáno v: | Frontline Gastroenterol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6583569/ https://ncbi.nlm.nih.gov/pubmed/31288252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/flgastro-2018-101049 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|